APA (7th ed.) Citation

Tedeschi, A., Greil, R., Demirkan, F., Robak, T., Moreno, C., Barr, P. M., . . . Gribben, J. G. (2020). A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Haematologica (Roma), 105(4), e164-e168. https://doi.org/10.3324/haematol.2019.223743

Chicago Style (17th ed.) Citation

Tedeschi, Alessandra, et al. "A Cross-trial Comparison of Single-agent Ibrutinib Versus Chlorambucil-obinutuzumab in Previously Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma." Haematologica (Roma) 105, no. 4 (2020): e164-e168. https://doi.org/10.3324/haematol.2019.223743.

MLA (9th ed.) Citation

Tedeschi, Alessandra, et al. "A Cross-trial Comparison of Single-agent Ibrutinib Versus Chlorambucil-obinutuzumab in Previously Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma." Haematologica (Roma), vol. 105, no. 4, 2020, pp. e164-e168, https://doi.org/10.3324/haematol.2019.223743.